| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2004 | EP1076645B1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP1042354B1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 03/03/2004 | EP1037615B1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 03/03/2004 | EP1032364B1 Topical compositions containing sialyl sugars and their derivatives |
| 03/03/2004 | EP1017692B1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/03/2004 | EP1014987B1 Oral compositions of levosimendan |
| 03/03/2004 | EP1007509B1 Antimicrobial compounds |
| 03/03/2004 | EP1007039B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 03/03/2004 | EP0998484B1 Method of identifying compounds having reduced systemic effects |
| 03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0938317B1 Compositions for reducing respiratory depression |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | EP0923366B1 Sunscreen compositions containing damaged rna fragments |
| 03/03/2004 | EP0906313B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/03/2004 | EP0893992B1 Fast disintegrating oral dosage form |
| 03/03/2004 | EP0879051B9 Rate-controlled transdermal administration of risperidone |
| 03/03/2004 | EP0874558B8 Liquid oral compositions comprising a calcium compound and an acidulant |
| 03/03/2004 | EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 03/03/2004 | EP0865430B1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
| 03/03/2004 | EP0865290B1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/03/2004 | EP0844879B1 Pharmaceutical compositions containing steroid derivatives involved in triggering an immune response |
| 03/03/2004 | EP0841916B9 Endothelin receptor antagonists |
| 03/03/2004 | EP0839033B1 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 03/03/2004 | EP0832900B1 Peptide and method of obtaining it |
| 03/03/2004 | EP0831850B1 Use of locally applied dna fragments |
| 03/03/2004 | EP0758333B1 Intermediates in pharmaceutical camptothecin preparation |
| 03/03/2004 | EP0749304B2 Slow-release tablet containing diclofenac-na |
| 03/03/2004 | EP0738268B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors |
| 03/03/2004 | EP0733103B1 Generation of high titers of recombinant aav vectors |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | CN1479872A Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing allosteric regulatory site |
| 03/03/2004 | CN1479871A Diagnostic and theraputic methods based on L1 adhesion molecule for ovarian and endometrial tumors |
| 03/03/2004 | CN1479749A Polysaccharide compound having immune stimulating activity |
| 03/03/2004 | CN1479747A Methylene steroids as novel androgens |
| 03/03/2004 | CN1479744A Crystalline glucosamine sulphate metal salts and its preparation method |
| 03/03/2004 | CN1479741A Process for isolation and purification of epothilones |
| 03/03/2004 | CN1479740A Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479737A Ethanolates of sodium-proton exchanger protein type-1 inhibitor |
| 03/03/2004 | CN1479736A Benzofuran and benzothiophene derivatives |
| 03/03/2004 | CN1479734A Arylated furane and thenoyl amine with potassium channel blocking effect |
| 03/03/2004 | CN1479728A Pexoxisome proliferator activated receptor alpha agonists |
| 03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |
| 03/03/2004 | CN1479725A N-alkoxyalkyl-substituted benzimidazoles and use thereof as active agent aginst parasitic protozoans |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1479722A Guanidine and amidine derivatives as factor Xa inhibitors |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479716A Propionic acid derivatives with PPAR-alpha activating properties |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479637A Composition and using method |
| 03/03/2004 | CN1479630A Method of inducing cancer cell death and tumor regression |
| 03/03/2004 | CN1479629A Combinations and compositions which interfere with VEGF/VEFG and anglopoietin/Tie receptor function and their use (II) |
| 03/03/2004 | CN1479628A Use of CYP206 inhibitors in combination therapies |
| 03/03/2004 | CN1479622A Treatment of cancers by aplidine in conjunction with myoprotector |
| 03/03/2004 | CN1479621A Treatment of urindry dysfunction |
| 03/03/2004 | CN1479620A Oral extended release formulation of gepirone |
| 03/03/2004 | CN1479619A Use of pyrazolo [4,3-d] pyrimidines |
| 03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
| 03/03/2004 | CN1479617A N-methyl-D-aspartate receptor agonist pharmaceutical compositions |
| 03/03/2004 | CN1479616A Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 03/03/2004 | CN1479614A Controlled release hydrocodone formulations |
| 03/03/2004 | CN1479613A Rapidly disintegrating tablet comprising acid-sensitive active ingredient |
| 03/03/2004 | CN1479611A Pharmaceutical paste comprising acid-labile activeingredient |
| 03/03/2004 | CN1479610A Drondearone pharmaceutical composition for external gastrointestinal-tract administration |
| 03/03/2004 | CN1479592A Method for precipitating red blood cells |
| 03/03/2004 | CN1479578A Anticholesterolemic edible oil |
| 03/03/2004 | CN1478902A Ganoderma mycellium antitumour water soluble neteropolysaccharide and its preparation method and use |
| 03/03/2004 | CN1478787A 3-glyeosyl flavone or its derivative and its preparation method and use |
| 03/03/2004 | CN1478783A Inositol polyphosphate ester derivative and its using method |
| 03/03/2004 | CN1478782A Germanium caffeiate and its preparation technology |
| 03/03/2004 | CN1478779A Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1478774A Andrographolide trimaleate mono potassium salt and androgra pholide dimaleate tripotassium salt and their medicinal composition |
| 03/03/2004 | CN1478770A 1,3-dicarbonyl compound and its preparation and use |
| 03/03/2004 | CN1478536A Proprietury Chinese medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method |
| 03/03/2004 | CN1478515A Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method |
| 03/03/2004 | CN1478494A Oral liquid for treating cough and asthma |
| 03/03/2004 | CN1478487A External use medicine for treating haemorrhoid |
| 03/03/2004 | CN1478485A Liposome ointment containing heparin kind medicine and its preparation method |
| 03/03/2004 | CN1478484A Antivirus medicine for raising immunity and its preaparation method |
| 03/03/2004 | CN1478483A Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
| 03/03/2004 | CN1478482A Slow release (controlled releuse) preparation of doufuguosu |
| 03/03/2004 | CN1478481A Etoposide enteric slow (controlled) release solid dispersing preparation and its preparation method |
| 03/03/2004 | CN1478480A Erigeron breviscapus slow release capsule and its preparation method |
| 03/03/2004 | CN1478479A New use of verbascum glycoside |
| 03/03/2004 | CN1478478A Medicinal composition for treating psoriasis |
| 03/03/2004 | CN1478477A Pectoral |
| 03/03/2004 | CN1478476A Medicine for treating venereal wart and its preparation method |
| 03/03/2004 | CN1478475A Diversine hydrochloride spray and its preparation process |
| 03/03/2004 | CN1478474A Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process |
| 03/03/2004 | CN1478473A Use of dihydromyricetrin and myricetrin contained composition in the preparation of medicine for lowering blooe sugar |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1478471A Iron zinc enriched nutritive water |